Suppr超能文献

在墨西哥第四波新冠疫情期间,利用基于污水的流行病学方法对奥密克戎和德尔塔变异株的流行情况进行检测与识别。

Omicron and Delta variant prevalence detection and identification during the fourth COVID-19 wave in Mexico using wastewater-based epidemiology.

作者信息

Aguayo-Acosta Alberto, Oyervides-Muñoz Mariel Araceli, Rodriguez-Aguillón Kassandra O, Ovalle-Carcaño Antonio, Romero-Castillo Kenya D, Robles-Zamora Alejandro, Johnson Marc, Parra-Saldívar Roberto, Sosa-Hernández Juan Eduardo

机构信息

Tecnologico de Monterrey, Institute of Advanced Materials for Sustainable Manufacturing, Monterrey, Mexico.

Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, Mexico.

出版信息

IJID Reg. 2023 Nov 10;10:44-51. doi: 10.1016/j.ijregi.2023.11.005. eCollection 2024 Mar.

Abstract

OBJECTIVES

To identify the SARS-CoV-2 variants Delta and Omicron during the fourth wave of the COVID-19 pandemic in Mexico using samples taken from 19 locations in 18 out of the 32 states.

METHODS

The genetic material concentration was done with PEG/NaCl precipitation, SARS-CoV-2 presence was confirmed by reverse transcriptase-quantitative polymerase chain reaction assay, the variant detection was carried out using a commercial mutation detection panel kit, and variant/mutation confirmation was done by amplicon sequencing of receptor-binding domain target region. The study used 41 samples.

RESULTS

The Delta variant was confirmed in two samples during August 2021 (Querétaro and CDMX) and in three samples during November 2021 (Aguascalientes, Ciudad Juárez campuses, and Nuevo Leon). In December 2021, another sample with the Delta variant was confirmed in Nuevo Leon. Between January to March 2022 only the presence of Omicron was confirmed, (variant BA.1). Additionally, in this period six samples were identified with the status "Variant Not Determined".

CONCLUSION

To our knowledge, this study is one of the first to identify Omicron and Delta variants with polymerase chain reaction in Mexico and Latin America and its distribution across the country with 56% Mexican states making it a viable alternative for variant detection without conducting a large quantity of sequencing of clinical tests.

摘要

目的

在墨西哥新冠疫情第四波期间,使用从32个州中18个州的19个地点采集的样本,鉴定严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的德尔塔和奥密克戎变体。

方法

通过聚乙二醇/氯化钠沉淀法进行遗传物质浓缩,采用逆转录定量聚合酶链反应测定法确认SARS-CoV-2的存在,使用商业突变检测试剂盒进行变体检测,并通过受体结合域目标区域的扩增子测序进行变体/突变确认。该研究使用了41个样本。

结果

2021年8月,在两个样本中确认了德尔塔变体(克雷塔罗州和墨西哥城),2021年11月,在三个样本中确认了德尔塔变体(阿瓜斯卡连特斯州、华雷斯城校区和新莱昂州)。2021年12月,新莱昂州又有一个样本被确认为德尔塔变体。2022年1月至3月期间,仅确认存在奥密克戎变体(BA.1变体)。此外,在此期间,有六个样本被鉴定为“未确定变体”状态。

结论

据我们所知,本研究是墨西哥和拉丁美洲首批通过聚合酶链反应鉴定奥密克戎和德尔塔变体及其在全国分布情况的研究之一,56%的墨西哥州都有该研究,这使其成为无需进行大量临床测试测序即可进行变体检测的可行选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8f8/10750064/6505da5cc4ab/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验